| Ms Catherine A Girard, APRN, DNP | |
|
200 W Town St, Norwich, CT 06360-2112 | |
| (860) 886-1508 | |
| Not Available |
| Full Name | Ms Catherine A Girard |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 200 W Town St, Norwich, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144396532 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 003312 (Connecticut) | Primary |
| Entity Name | Comprehensive Psychiatric Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982783247 PECOS PAC ID: 3072683853 Enrollment ID: O20080605000359 |
News Archive
For more than 400 years, scientists have studied the amazing regenerative power of salamanders, trying to understand how these creatures routinely repair injuries that would usually leave humans and other mammals paralyzed - or worse.
"[C]ompassion and a sense of justice can motivate" the Washington, D.C., community "to do more" for people living with HIV/AIDS in the district, Patricia Wudel - executive director of Joseph's House, which provides hospice services for HIV-positive people - writes in a Washington Post opinion piece in response to an earlier opinion piece by columnist Courtland Milloy (Wudel, Washington Post, 3/29).
Jose Ramon Sarasua and Aitor Larra-aga, researchers in the materials engineering department of the UPV/EHU-University of the Basque Country, have been studying new materials or implants that are of interest in medicine and in helping to mend bones, in particular.
KemPharm, Inc. announced today that it has received a Notice of Issuance from the United States Patent and Trademark Office (USPTO) for its patent application entitled "Polar Hydrophilic Prodrugs of Amphetamine and Other Stimulants and Processes for Making and Using the Same", U.S. Patent No. 7,772,222. This patent protects broad aspects of the Company's core Ligand Activated Therapy (LAT) prodrug technology platform and its application to the treatment of Attention Deficit – Hyperactivity Disorder.
Targeted Genetics Corporation has announced the issuance of another patent related to the Company's leading adeno-associated virus (AAV) technology platform. U.S. patent #6,897,045, titled "Adeno-Associated Virus Vectors," was issued to the University of Iowa Research Foundation and is exclusively licensed to Targeted Genetics.
› Verified 3 days ago
| Entity Name | Harvest Healthcare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477712917 PECOS PAC ID: 9931276979 Enrollment ID: O20080917000499 |
News Archive
For more than 400 years, scientists have studied the amazing regenerative power of salamanders, trying to understand how these creatures routinely repair injuries that would usually leave humans and other mammals paralyzed - or worse.
"[C]ompassion and a sense of justice can motivate" the Washington, D.C., community "to do more" for people living with HIV/AIDS in the district, Patricia Wudel - executive director of Joseph's House, which provides hospice services for HIV-positive people - writes in a Washington Post opinion piece in response to an earlier opinion piece by columnist Courtland Milloy (Wudel, Washington Post, 3/29).
Jose Ramon Sarasua and Aitor Larra-aga, researchers in the materials engineering department of the UPV/EHU-University of the Basque Country, have been studying new materials or implants that are of interest in medicine and in helping to mend bones, in particular.
KemPharm, Inc. announced today that it has received a Notice of Issuance from the United States Patent and Trademark Office (USPTO) for its patent application entitled "Polar Hydrophilic Prodrugs of Amphetamine and Other Stimulants and Processes for Making and Using the Same", U.S. Patent No. 7,772,222. This patent protects broad aspects of the Company's core Ligand Activated Therapy (LAT) prodrug technology platform and its application to the treatment of Attention Deficit – Hyperactivity Disorder.
Targeted Genetics Corporation has announced the issuance of another patent related to the Company's leading adeno-associated virus (AAV) technology platform. U.S. patent #6,897,045, titled "Adeno-Associated Virus Vectors," was issued to the University of Iowa Research Foundation and is exclusively licensed to Targeted Genetics.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Catherine A Girard, APRN, DNP 19 Concord St, Glastonbury, CT 06033-2135 Ph: (860) 916-6244 | Ms Catherine A Girard, APRN, DNP 200 W Town St, Norwich, CT 06360-2112 Ph: (860) 886-1508 |
News Archive
For more than 400 years, scientists have studied the amazing regenerative power of salamanders, trying to understand how these creatures routinely repair injuries that would usually leave humans and other mammals paralyzed - or worse.
"[C]ompassion and a sense of justice can motivate" the Washington, D.C., community "to do more" for people living with HIV/AIDS in the district, Patricia Wudel - executive director of Joseph's House, which provides hospice services for HIV-positive people - writes in a Washington Post opinion piece in response to an earlier opinion piece by columnist Courtland Milloy (Wudel, Washington Post, 3/29).
Jose Ramon Sarasua and Aitor Larra-aga, researchers in the materials engineering department of the UPV/EHU-University of the Basque Country, have been studying new materials or implants that are of interest in medicine and in helping to mend bones, in particular.
KemPharm, Inc. announced today that it has received a Notice of Issuance from the United States Patent and Trademark Office (USPTO) for its patent application entitled "Polar Hydrophilic Prodrugs of Amphetamine and Other Stimulants and Processes for Making and Using the Same", U.S. Patent No. 7,772,222. This patent protects broad aspects of the Company's core Ligand Activated Therapy (LAT) prodrug technology platform and its application to the treatment of Attention Deficit – Hyperactivity Disorder.
Targeted Genetics Corporation has announced the issuance of another patent related to the Company's leading adeno-associated virus (AAV) technology platform. U.S. patent #6,897,045, titled "Adeno-Associated Virus Vectors," was issued to the University of Iowa Research Foundation and is exclusively licensed to Targeted Genetics.
› Verified 3 days ago
Mafe Duyan Rato, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 624 W West Main St, St 140, Norwich, CT 06360 Phone: 860-200-8098 | |
Meagan Gates, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 372 W Main St, Norwich, CT 06360 Phone: 860-887-5970 | |
Mrs. Polina Verbitsky-havasov, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 42 Town St Ste 300, Norwich, CT 06360 Phone: 860-886-0567 Fax: 860-886-0656 | |
Sarah Jean Robertson, MSN, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 606 W Main St, Norwich, CT 06360 Phone: 860-889-1400 | |
Ms. Lindsay Anne Bizzaro, NNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 326 Washington St, Norwich, CT 06360 Phone: 614-378-1802 | |
Jessica Banning, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Lathrop Ave, Norwich, CT 06360 Phone: 860-204-0883 | |
Olubunmi Olugbile, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 326 Washington St, Norwich, CT 06360 Phone: 860-889-8331 |